MVA85A vaccine to enhance BCG for preventing tuberculosis-Reference-Cited by-同舟云学术

MVA85A vaccine to enhance BCG for preventing tuberculosis

Published:2018-01-09 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Kashangura Rufaro¹,Jullien Sophie²,Garner Paul³,Young Taryn⁴⁵,Johnson Samuel³

Affiliation:

1. Nhlangano Health Centre; Box 29 Nhlangano Swaziland

2. Jigme Dorji Wangchuck National Referral Hospital; Thimphu Bhutan

3. Liverpool School of Tropical Medicine; Department of Clinical Sciences; Pembroke Place Liverpool Merseyside UK L3 5QA

4. Stellenbosch University; Centre for Evidence-based Health Care, Division of Epidemiology and Biostatistics, Faculty of Medicine and Health Sciences; PO Box 241 Cape Town South Africa 8000

5. South African Medical Research Council; Cochrane South Africa; PO Box 19070 Tygerberg Cape Town South Africa 7505

Publisher

Wiley

Subject

Pharmacology (medical)

Reference81 articles.

1. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis;Abubakar;Health Technology Assessment,2013

2. Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases;Altenburg;Viruses,2014

3. The impact of diabetes on tuberculosis treatment outcomes: a systematic review;Baker;BMC Medicine,2011

4. Rational approach to selection and clinical development of TB vaccine candidates;Barker;Tuberculosis,2012

5. Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations;Beveridge;European Journal of Immunology,2007

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MVA85A vaccine to enhance BCG for preventing tuberculosis;Cochrane Database of Systematic Reviews;2019-04-30